AGC to Expand Chemical and API Capacity

News
Article

The glass and chemical provider will expand its synthetic pharmaceutical intermediate and API production capacity at its plant in Chiba, Japan.

In a July 12, 2018 press release, AGC, a manufacturer of glass and chemicals, announced plans to expand facilities at its Chiba, Japan, site to increase the company’s synthetic pharmaceutical intermediate and API production capacity. 

According to the company, the new capacity will increase production at the Chiba plant tenfold and is set to come online in October 2019.

Previously, AGC primarily provided contract development and manufacturing services for the development stage of new drugs, but this new expansion will allow the company to provide end-to-end capability to also produce commercial drugs, the company reports. Additionally, the new facilities will be capable of producing hard-to-handle active ingredients, such as the highly potent APIs typically used in cancer therapy.

Source: AGC

Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content